Using deep brain stimulation to map dysfunctional brain circuits linked to four disorders

Mass General Brigham researchers identified sets of connections that are disrupted and malfunctioning as a consequence of Parkinson’s disease, dystonia, obsessive compulsive disorder and Tourette’s syndrome.

BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement | Psychedelic Invest

BetterLife Pharma Inc. (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce

September 5, 2023

Endpoints 11 winner Cardurion Pharmaceuticals: A shot at one of heart disease’s ‘undruggable’ targets

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 27, 2024

Senators call on FDA to address ‘deluge of misleading promotions’ on social media

Senators across both sides of the aisle are calling for a “swift” update to the FDA’s guidance on prescription drug promotion. Sens. Mike Braun (R-IN)

February 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.